Cargando…
Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure
Antiplatelet agents, sarpogrelate (SAR), a 5-HT(2A) receptor antagonist, and cilostazol (CIL), a phosphodiesterase III (PDE-III) inhibitor, are used for the treatment of peripheral vascular disease. We tested whether these agents affect cardiac function and subcellular remodelling in congestive hear...
Autores principales: | Sanganalmath, Santosh K, Babick, Andrea P, Barta, Judit, Kumamoto, Hideo, Takeda, Nobuakiya, Dhalla, Naranjan S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918089/ https://www.ncbi.nlm.nih.gov/pubmed/18088389 http://dx.doi.org/10.1111/j.1582-4934.2007.00197.x |
Ejemplares similares
-
β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011) -
Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction
por: Babick, Andrea, et al.
Publicado: (2012) -
Mechanisms of the Beneficial Actions of Ischemic Preconditioning on
Subcellular Remodeling in Ischemic-Reperfused Heart
por: Müller, By Alison L, et al.
Publicado: (2010) -
Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease
por: Dhalla, Naranjan S., et al.
Publicado: (2022) -
Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy
por: Dhalla, Naranjan S., et al.
Publicado: (2020)